Aion Pharma Ltda. (Brazil)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

Secondary Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Pharmacies and Drug Stores | All Other Miscellaneous Store Retailers (except Tobacco Stores) | General Warehousing and Storage | Data Processing, Hosting, and Related Services | Lessors of Nonfinancial Intangible Assets (except Copyrighted Works) | Architectural, Engineering, and Related Services | Engineering Services | Computer Systems Design and Related Services | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences | All Other Professional, Scientific, and Technical Services | Office Administrative Services | Document Preparation Services | Other Support Services | Professional and Management Development Training | Educational Support Services

Full name: Aion Pharma Ltda.

Profile Updated: September 29, 2026

Aion Pharma Ltda. is an enterprise based in Brazil. Its main office is in Santana de Parnaiba. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on August 31, 2026.

Headquarters
Alameda Dali 46, Sala 1, Alphaville
Santana de Parnaiba; Sao Paulo; Postal Code: 06539330

Contact Details: Purchase the Aion Pharma Ltda. report to view the information.

Basic Information

Registered Capital:

Purchase the Aion Pharma Ltda. report to view the information.

Financial Auditors:

Purchase the Aion Pharma Ltda. report to view the information.

Incorporation Date:

August 31, 2026

Key Executives

Purchase this report to view the information.

Director

Ownership Details

Purchase this report to view the information.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service